EP Patent

EP1774961A2 — Methods for stabilizing ophthalmic compositions

Assigned to Johnson and Johnson Vision Care Inc · Expires 2007-04-18 · 19y expired

What this patent protects

The present invention relates to a method comprising stabilizing, during autoclaving, an oxidatively unstable ophthalmic compound dissolved in an ophthalmic solution by incorporating a stabilizing effective amount of at least one electron rich polymer in said ophthalmic solution.

USPTO Abstract

The present invention relates to a method comprising stabilizing, during autoclaving, an oxidatively unstable ophthalmic compound dissolved in an ophthalmic solution by incorporating a stabilizing effective amount of at least one electron rich polymer in said ophthalmic solution.

Drugs covered by this patent

Patent Metadata

Patent number
EP1774961A2
Jurisdiction
EP
Classification
—
Expires
2007-04-18
Drug substance claim
No
Drug product claim
No
Assignee
Johnson and Johnson Vision Care Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.